Goldstein, David J.
Eli Lilly (United States) · Indiana University School of Medicine · University of Cincinnati
5 papers on CoChatORCID 0000-0003-3654-8142
Most cited papers
- Verified
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
Arnold, L. M., Lu, Y., Crofford, L. J., Wohlreich, M., Detke, M. J., Iyengar, S., & Goldstein, D. J. (2004) · Arthritis & Rheumatism
Fibromyalgia and Chronic Fatigue Syndrome ResearchPain Mechanisms and Treatments
Cited by 624
- Verified
A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder
Arnold, L. M., Rosen, A., Pritchett, Y. L., D'Souza, D. N., Goldstein, D. J., Iyengar, S., & Wernicke, J. F. (2005) · Pain
Fibromyalgia and Chronic Fatigue Syndrome ResearchPain Mechanisms and Treatments
Cited by 471
- Verified
Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial
Detke, M. J., Lu, Y., Goldstein, D. J., Hayes, J. R., & Demitrack, M. A. (2002) · The Journal of Clinical Psychiatry
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 384
- Verified
Duloxetine in the Treatment of Major Depressive Disorder: A Double-Blind Clinical Trial
Goldstein, D. J., Mallinckrodt, C., Lu, Y., & Demitrack, M. A. (2002) · The Journal of Clinical Psychiatry
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 334
- Verified
Duloxetine in the Treatment of Depression: A Double-Blind Placebo-Controlled Comparison With Paroxetine
Goldstein, D. J., Lu, Y., Detke, M. J., Wiltse, C., Mallinckrodt, C., & Demitrack, M. A. (2004) · Journal of Clinical Psychopharmacology
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 314
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free